Introduction {#s1}
============

Pathology imaging informatics refers to the analytical and computational methods for handling, analyzing, and exploring histopathological images and their associated clinical data in order to achieve a medical goal, for example, diagnostic or prognostic applications.[@R1; @R2; @R3; @R4; @R5; @R6] Histopathological analysis is a common clinical procedure for diagnosing the presence, type, and progression of diseases such as cancer. While diagnosing cancer patients using biopsy-derived tissue slides, pathologists manually identify the most progressed regions and examine nuclear morphology, among other tissue and cellular properties. However, manual examination and decision-making using tissue slides that may potentially contain millions of cells can be time-consuming and subjective. Researchers have thus proposed clinical decision support systems (CDSS) and informatics methods that can help in decision-making by objectively quantifying morphological properties in histopathological images. Many of these systems and informatics methods still focus on images that represent only limited, manually selected regions of tissue slides rather than on whole-slide images (WSI).[@R5] By including an element of manual selection in these CDSS, researchers have ensured higher quality and disease-relevant input images while decreasing computational complexity.[@R7] However, manually selected tissue slide regions do not capture the complete information available to pathologists during initial microscopic analysis. Moreover, they are subject to biases related to the knowledge of the pathologist that selected the image regions.[@R7] Therefore, we focus on WSI analysis methods that can potentially maximize the amount of information extracted from tissue slides for decision-making and maximize the objectivity and reproducibility of analysis. In particular, we review methods for quality control, representation of WSI using various types of quantitative image features, predictive modeling, and visualization and exploratory analysis ([figure 1](#AMIAJNL2012001540F1){ref-type="fig"}). This review is by no means a comprehensive description of WSI informatics. However, compared to recent reviews on WSI informatics[@R4] [@R6] [@R8] that highlight general challenges and applications, we discuss state-of-the-art analytical methods in the key components of WSI-based CDSS.

![An example clinical decision support system for quantitative analysis of whole-slide images (WSI) of tissue biopsy samples. This system has the following key components: quality control to ensure only high-quality data are processed, image description to convert WSI into quantitative features, prediction modeling to develop quantitative diagnostic models, and exploratory analysis to interpret the image feature space. We include two case studies as examples of predictive modeling and exploratory analysis. ROI, region of interest.](amiajnl-2012-001540f01){#AMIAJNL2012001540F1}

The importance of quantitative and objective analysis of tissue biopsy WSI has led to several commercial software tools for WSI analysis including GENIE (Aperio, Vista, California, USA), HALO (Indica Labs, Corrales, New Mexico, USA), AQUA Analysis (HistoRx, Branford, Connecticut, USA), and Visiopharm (Hoersholm, Denmark). However, all of these tools provide limited image processing capabilities. In most cases, pathologists manually select the regions of interest (ROI) and make diagnoses based on feedback from these commercial tools. Usually, an expert user calibrates these systems for each laboratory-specific experimental setup. To the best of our knowledge, none of these tools provides complete data analysis for clinical decision-making that includes all of the steps illustrated in [figure 1](#AMIAJNL2012001540F1){ref-type="fig"}.

Patient-level prediction modeling and exploratory analysis is important for a number of clinical applications including diagnostics and therapeutics.[@R9] The importance of accurate image-based disease diagnosis and the development of novel pathology informatics techniques has led to the establishment of databases such as the NCI Cooperative Prostate Cancer Tissue Resource,[@R10] the NIH Cancer Genome Atlas (TCGA),[@R11] and the Human Protein Atlas.[@R12] Such databases provide a large number of high-quality histopathological images and associated clinical data, further stimulating the development of novel informatics methods. Some of these databases also provide matched genomic and proteomic data, enabling multimodal studies that associate '--omic' data with histopathological image features. We use WSI from TCGA in a case study to demonstrate a CDSS that identifies and eliminates image artifacts such as tissue folds, extracts image features using piecewise analysis, identifies biologically relevant WSI regions, and combines image features from selected WSI regions to predict several clinical endpoints.

Quality control {#s2}
===============

The quality of histopathological WSI is usually affected by artifacts acquired during image acquisition and batch effects resulting from variations in experimental protocol. Both of these issues can affect the results of downstream clinical applications. Data quality is especially challenging in collaborative repositories, such as TCGA, where a large amount of high-throughput data is collected from multiple institutions.

Image artifacts {#s2a}
---------------

Errors in biopsy slide preparation or in microscope parameters may lead to anomalies, known as image artifacts, in WSI. Common image artifacts include tissue folds, blurred regions, pen marks, shadows, and chromatic aberrations.[@R6] [@R8] Image artifacts have unpredictable effects on image segmentation and other quantitative image features. Therefore, it is essential either to eliminate or correct these artifacts. Tissue-fold artifacts, caused by layering of non-adherent tissue on the slide, can be eliminated using methods based on color saturation and intensity.[@R13; @R14; @R15] [Figure 2](#AMIAJNL2012001540F2){ref-type="fig"} illustrates some results for eliminating tissue folds and pen marks in WSI using color properties.[@R13] [@R14] Briefly, we detect tissue folds by using an unsupervised method to cluster the pixels in an image representing the difference between saturation and intensity values for every pixel.[@R14] Because of its unsupervised nature, this method has two limitations: it has low sensitivity for an image with different types of tissue folds and it has low specificity for an image with no tissue folds. Blurred regions, caused by loss of microscope focus, can be detected using a supervised model based on texture properties such as gradient, Laplacian, local grayscale statistics, and wavelet response.[@R16] However, the success of such models depends on good quality annotated data for training. Chromatic aberrations occur when light dispersion through the microscopic lens varies with colors, leading to ghost colors along the edges of objects or discontinuities in an image. Wu *et al*[@R17] suggest a method that quantifies the amount of color dispersion at the object edges and realigns color components to correct chromatic aberration. Although artifact correction and elimination is essential for robust downstream analysis, literature on the topic is relatively sparse. Moreover, most proposed methods have only been tested on a limited set of images as a proof of concept.

![Eliminating tissue-fold artifacts and pen marks in a whole-slide image of a NIH Cancer Genome Atlas ovarian serous carcinoma biopsy.](amiajnl-2012-001540f02){#AMIAJNL2012001540F2}

Batch effects {#s2b}
-------------

Differences in slide preparation, microscope, and digitizing device between two batches of data may lead to differences in image properties between the two batches. These differences, called batch effects, can bias the performance estimates of predictive models. Histopathological images often suffer from color and scale batch effects. Color batch effects can be addressed by normalizing the color of an image to a reference image[@R18; @R19; @R20] or by converting the image to a color space (eg, CIELAB) that is not affected by color batch effects.[@R21; @R22; @R23] [Figure 3](#AMIAJNL2012001540F3){ref-type="fig"} illustrates results for normalizing the color map of two ovarian samples (obtained from TCGA) using color-map quantile normalization.[@R18] Color normalization can be performed either at the pixel level using a single model for a complete image[@R18] or at the stain level using a different model for each stain.[@R20] Pixel-level normalization is affected by differences in morphology between the reference and test images while stain-level normalization is affected by the accuracy of stain segmentation. Unlike color batch effects, which affect only color properties of an image, scale batch effects can affect a variety of image features such as object size, topology, and texture. However, scale batch effects may be difficult to detect or correct because biological factors such as cancer grade or subtype may induce changes in scale. Such batch effects may be detected by examining the differences in distribution of image features between batches. For example, Kothari *et al*[@R24] detected and proposed a method for correcting scale batch effects by examining the distributions of nuclear areas. Studies suggest that batch effects, if left uncorrected, can severely reduce the performance of genomic prediction models.[@R25] [@R26] Even though preliminary investigations suggest that batch effects are present in histopathological images, most researchers validate their diagnostic models on a single image dataset collected during a single experimental set-up. For clinical application of these systems, it is essential to validate diagnostic models on multiple datasets and to develop effective batch-effect removal methods.

![Normalization of color batch effects in ovarian samples provided by the NIH Cancer Genome Atlas.](amiajnl-2012-001540f03){#AMIAJNL2012001540F3}

Quantitative image description {#s3}
==============================

WSI data may be described by experimental and clinical-level features (eg, acquisition-related specifications and patient diagnoses) as well as content-based image properties. Content-based features, which are informative for quantitative prediction modeling and for exploratory analysis, can be categorized into three levels---pixel, object, and semantic-level features---based on the amount of raw data captured by the features and the biological interpretability of the features ([figure 4](#AMIAJNL2012001540F4){ref-type="fig"}).[@R27] [@R28]

![Representation of a (A) NIH Cancer Genome Atlas whole-slide image (WSI) of a kidney renal clear cell carcinoma biopsy using various quantitative features extracted from (B) a single image tile. Quantitative features include pixel-level features, ie, (C) color histogram and (D) Gabor filter response; object-level features, ie, (E) segmented shapes and (F) graph-based topology; and semantic-level features, ie, (G) percentage of high-level clinical properties.](amiajnl-2012-001540f04){#AMIAJNL2012001540F4}

Pixel-level features {#s3a}
--------------------

Pixel-level image features are in the lowest level of the information hierarchy because they are the least interpretable in terms of biology. Pixel-level image features do not focus on any specific set of pixels in a WSI. Rather, they consider all image pixels and capture properties such as color and texture. Color features quantify color spread, prominence and co-occurrence using statistics and frequencies of color histograms in different color spaces including red-green-blue,[@R29; @R30; @R31] hue-saturation-value,[@R32] CIELUV,[@R33] and CIELAB[@R22] [@R34] ([figure 4](#AMIAJNL2012001540F4){ref-type="fig"}C). Texture features quantify image sharpness, contrast, changes in intensity, and discontinuities or edges by measuring properties derived from gray-level intensity profiles,[@R30] Haralick gray-level co-occurrence matrix (GLCM) features,[@R23] [@R30] [@R35] [@R36] wavelet and multiwavelet submatrices,[@R30] [@R35; @R36; @R37] Gabor filter responses[@R23] [@R30] [@R36] ([figure 4](#AMIAJNL2012001540F4){ref-type="fig"}D), and fractals.[@R30] [@R36]

Despite the lack of biological interpretability, pixel-level features are used extensively in data-driven models because they are simple to extract and are useful (at times sufficient) to describe the images. For example, features from eight color spaces were successfully used for skin melanoma classification,[@R38] gray-level multiwavelet features for prostate grading,[@R37] and color texture (GLCM) properties for follicular lymphoma grading.[@R39] [Figure 4](#AMIAJNL2012001540F4){ref-type="fig"} illustrates some pixel-level features including red-green-blue color histograms and Gabor filter textures at various scales.

Object-level features {#s3b}
---------------------

Object-level features are in a higher level of the information hierarchy compared to pixel-level features because they describe properties of the cellular structures---such as nuclei, cytoplasm, and glands---in a WSI. To extract object-based features, it is essential first to segment cellular structures. As cellular structures appear in different colors in a stained histopathological sample, researchers have proposed color-based methods for segmentation. The literature supports both semi-automatic methods, with some user interaction,[@R35] [@R40] as well as completely automatic methods[@R18] [@R41; @R42; @R43] for segmentation. To increase the accuracy of segmentation, some researchers consider the pixel neighborhood properties using graph cut,[@R39] object graph,[@R44] and Markov models.[@R45] The accuracy of image segmentation methods greatly affects the robustness of downstream analysis. [Figure 4](#AMIAJNL2012001540F4){ref-type="fig"}E illustrates a pseudo-colored segmentation mask, in which blue, pink, and white represent nuclear, cytoplasmic, and no-stain/gland regions, respectively.[@R18] Object-level features describe the shape, texture, and spatial distribution of cellular structures in a WSI.

Shape-based features can be broadly categorized into contour and region-based features ([figure 4](#AMIAJNL2012001540F4){ref-type="fig"}E).[@R46] Contour-based features include the properties of shape boundary such as perimeter, boundary fractal dimension, and bending energy. They also include coefficients of parametric shape models such as Fourier shape descriptors and elliptical models.[@R47] Region-based features include area, solidity, and Zernike moments.[@R48] Among all shape features, the properties of elliptical shape models of a nuclear boundary are most prevalent in pathology informatics because they are simple to extract and interpret, and informative for cancer endpoints.[@R39] [@R48; @R49; @R50; @R51]

Object-level texture features are similar to pixel-level texture features, except that they capture the texture of only a subset of image pixels associated with a tissue object.[@R30] Nuclear texture is reported to be very informative for separating malignant regions,[@R51] subtyping cancer,[@R49] and grading cancer.[@R30]

Topological or architectural features can capture the spatial distribution of cellular structures in a tissue sample. Researchers have found spatial graphs (eg, Deluanay triangulations, Voronoi diagrams, and minimum spanning trees), in which graph nodes are centers of cellular (nuclear or cytoplasmic) structures, to be useful for extracting topological features ([figure 4](#AMIAJNL2012001540F4){ref-type="fig"}F). Common topological features include properties of spatial graphs such as edge length, connectedness, and compactness. Besides graph-based properties, topological properties include object density, average distance between neighbors, and the number of objects within a given neighborhood. Architectural features are useful for cancer endpoints such as grading,[@R30] [@R39] classifying tumor versus non-tumor regions,[@R52] [@R53] classifying low versus high lymphocytic infiltration regions,[@R54] and predicting patient prognosis.[@R55] [@R56]

In comparison to pixel-level features, object-level descriptors can be much more computationally expensive to extract due to their dependence on image segmentation. Therefore, in light of the diagnostic benefit and biological interpretability of object-level features, more research is necessary to improve the computational speed of object-level feature extraction using methods such as parallel computing and graphical processing units.

Semantic-level features {#s3c}
-----------------------

Most pixel and object-level features are difficult to interpret biologically and are susceptible to noise. In contrast, semantic-level features easily capture interpretable high-level concepts such as the presence or absence of nucleoli, necrosis, and lymphocytes ([figure 4](#AMIAJNL2012001540F4){ref-type="fig"}G). A semantic feature is usually a classification or statistical rule based on a subset of low-level features (eg, low-level properties such as nuclear texture, color, and gray-level distribution may capture the high-level concept of nucleolus presence in a nucleus). Because not all low-level features may be useful for capturing high-level biological concepts, CDSS often use feature-preprocessing methods to select a subset of the original or transformed features. Among these preprocessing methods, the bag-of-features method is the one most commonly used for semantic features.[@R57; @R58; @R59] As semantic-level features require a large amount of annotated training data, only a few systems use these features.[@R60; @R61; @R62] There is thus limited research on semantic-level descriptors for histopathology. However, with the large amount of biological variations in WSI because of the heterogeneity of cancer biology, it will be especially beneficial to continue developing and refining semantic-level image descriptors.

Predictive modeling {#s4}
===================

Predictive modeling is an important part of pathology imaging informatics because it is applicable to a number of diagnostic clinical endpoints. Three important steps of WSI prediction modeling include: ROI selection and tile-based WSI representation; informative feature selection and reduction; and classification. We discuss ROI selection and tile-based WSI representation in detail in the following section. As the number of image features is generally much larger than the number of available samples, predictive modeling in pathology imaging informatics faces similar algorithmic challenges as that of other informatics fields. As described in the supplementary methods (available online only), feature selection, feature reduction, and classification methods address the problem of robust model building based on high-dimensional data.

ROI selection and tile-based WSI representation {#s4a}
-----------------------------------------------

A high-resolution scan of a tissue biopsy slide results in a very large WSI (eg, up to 40 000×60 000 pixels). Such WSI contain a large amount of biologically related spatial variation including regions of high-grade tumor, low-grade tumor, necrosis, and stroma. When pathologists examine a WSI, they identify regions that are most important or relevant for the final prognostic decision (eg, the region with the highest cancer grade). Similarly, an informatics system aims to identify a ROI in the WSI before developing a predictive model. Several researchers have developed supervised models for identifying ROI in WSI, but these methods require previous annotation for training.[@R13] [@R63; @R64; @R65] Researchers have recently proposed unsupervised knowledge-based methods for identifying ROI.[@R66] [@R67]

Because of limitations in computer memory and processing time, WSI are often cropped into smaller tiles (eg, 512×512-pixel tiles), and then features are extracted from each tile in parallel.[@R13] [@R22] [@R65] [@R67; @R68; @R69] Representation of WSI by combining data from multiple WSI tiles is an emerging area of research with limited published results, especially in the context of clinical prediction.[@R22] [@R49] After identifying tiles corresponding to ROI, an informatics system can either combine the tiles to represent the WSI in a prediction model[@R49] or predict the label for individual tiles and then combine labels to represent the final prediction result of the WSI.[@R22] In the former method, outlier features might dominate WSI properties. In the latter method, annotation of individual tiles, instead of the WSI, might be necessary for training models. In the case study, we demonstrate a simple method for combining features from multiple tiles and show that this method yields reasonable clinical prediction results. A related topic to piecewise analysis of WSI is multiresolution or multiscale analysis, in which a WSI is processed at various scales/resolutions to achieve different modeling objectives.[@R22] [@R23] [@R67] [@R70] The basic concept of multiscale analysis is that a coarse level of prediction---such as tumor and non-tumor classification---can be achieved at a low resolution, when WSI are smaller and processing time is shorter. In contrast, for more complex problems such as grade prediction, WSI need to be processed at higher resolution.

Most WSI are millions of pixels in size and capture a large amount of biological heterogeneity. It is thus necessary to develop automatic methods for accurately selecting ROI in WSI. Without accurate ROI selection, the prediction performance of decision support systems for WSI may suffer compared to that for manually selected image portions. In order to achieve automatic ROI selection, we need to develop representation methods that capture high-level biological heterogeneity in WSI (ie, regions of high/low-grade cancer or regions of tissue necrosis). These methods can be as simple as capturing pathologists' annotations for biological heterogeneity, then using these annotations to train automatic ROI selection methods. Such models will not only aid in WSI-based patient prediction modeling but will also aid in exploratory analysis for discovering factors that lead to differential clinical outcomes.

Visualization and exploratory analysis {#s5}
======================================

Pathology imaging informatics has traditionally focused on predictive modeling. However, the research focus has evolved into a combination of predictive modeling and exploratory analysis for two reasons. First, large-scale studies such as TCGA aim to reveal new insights about aggressive cancer endpoints and to discover new prognostically different subtypes. Second, predictive modeling with high-dimensional data is very difficult and requires tools for interpreting the biological relevance of features and quantitative models.

Unsupervised clustering and high-dimensional feature patterns {#s5a}
-------------------------------------------------------------

Patterns in image features can be captured in simple two or three-dimensional visualizations such as scatter plots, surface plots, and distribution curves.[@R35] [@R39] [@R51] [@R54] [@R56] [@R71] However, if the number of descriptors is very large (\>50), such visualizations may be difficult to implement or interpret. Therefore, unsupervised clustering methods are useful for reducing the feature space before visualization. Common clustering techniques in pathology imaging informatics include hierarchal clustering, self-organizing maps, and k-means. Hierarchal clustering is useful for patient stratification and visualization.[@R49] [@R68] [@R72; @R73; @R74] Self-organizing maps are commonly used for feature interpretation,[@R75] patient stratification[@R76] and segmentation[@R39] [@R77] [@R78] in pathology imaging informatics systems. k-Means is mostly used for color segmentation[@R79] and for image classification and visualization as part of the bag-of-features representation.[@R58] [@R80] All of these methods are useful for visualizing the underlying structure of high-dimensional representations of histopathological data.

Virtual microscope and spatial patterns {#s5b}
---------------------------------------

With the availability of large histopathological data repositories such as TCGA, 'virtual microscope' software applications have emerged that enable the spatial exploration of high-resolution digital WSI.[@R1] [@R68] [@R81] [@R82] Without such applications, it is a challenge to share or even to view these images in real time. In addition, researchers have developed compression methods specifically for WSI.[@R83] [@R84] The popularity of the Google Maps interface for exploring satellite images at many different detail levels has inspired similar tools for exploring whole-slide tissue images.[@R82] [@R85] [@R86] In addition to viewing a WSI, some systems can highlight ROI (eg, regions of high-grade cancer or regions with lymphocyte infiltration).[@R56] [@R64] [@R65] [@R67] [@R70] [@R87] Moreover, some visualizations annotate histopathological images with semantic labels such as necrosis, glands, and lymphocytes,[@R61] [@R62] or highlight the spatial distributions of proteins, image features, or biomarker expression across the histopathological image.[@R13] [@R71]

Both spatial and patient-level exploratory analysis of WSI is an open area of research that requires interdisciplinary collaborations among pathologists, biologists, and computer scientists. Such collaboration is necessary to tackle the difficult problem of discovering and interpreting novel patterns in histopathological data that may lead to improved patient care. Moreover, it is necessary to develop novel quantitative metrics for assessing the stability and reproducibility of patterns related to both spatial and patient-level analysis to ensure that these patterns are biologically relevant. The supplemental case study illustrates a method for exploring spatial patterns in WSI.

Case study: tile-based ROI selection for WSI prediction modeling {#s6}
================================================================

In this case study, we examine the effect of WSI ROI selection on the prediction performance of clinical endpoints. We use 906 WSI of tumor samples from 451 kidney renal clear cell carcinoma (KiCa) patients from TCGA.[@R11] As described in supplement 1 (available online only), information extraction from quality-controlled WSI include the following steps: tile segmentation; image feature extraction; tumor detection; and patient representation using tissue (tumor and non-tumor tiles) or tumor tiles. Using the clinical data from TCGA, we develop WSI-based decision models for five binary endpoints ([table 1](#AMIAJNL2012001540TB1){ref-type="table"}). Prediction models use classifiers based on discriminant analysis---linear, quadratic, spherical and diagonal---and minimum-redundancy, maximum-relevance (mRMR) feature selection.[@R88] We optimize feature size in the range of 1 to 100 and classifier parameters using five-fold, 10 iterations of nested cross-validation. The optimized models have average feature size in the range of 28 to 74 ([table 2](#AMIAJNL2012001540TB2){ref-type="table"}). Among all feature subsets, the nuclear shape subset is statistically overrepresented for most endpoints, which implies that nuclear shape features are most informative for these endpoints ([table 2](#AMIAJNL2012001540TB2){ref-type="table"}).[@R30]

###### 

Prediction performance for whole-slide image-based binary endpoints

                       Class 1                           Class 2   AUC for outer cross-validation                                 
  -------------------- --------------------------------- --------- -------------------------------- ----- ----------- ----------- --------
  Histological grade   Grade 1 or 2                      204       Grade 3 or 4                     239   0.66±0.01   0.69±0.01   0.0000
  Metastasis           No spread to other organs         381       Spread to other organs           68    0.61±0.01   0.64±0.01   0.0001
  Stage                Stage I or II                     267       Stage III or IV                  182   0.60±0.02   0.61±0.03   0.0562
  Five-year survival   \<5 years                         126       ≥5 years                         101   0.54±0.02   0.57±0.02   0.0151
  Lymphnode spread     No spread to nearby lymph nodes   210       Spread to nearby lymph nodes     17    0.56±0.06   0.54±0.02   0.5148

AUC, area under the curve.

###### 

Statistically overrepresented feature subsets in models based on tumor tiles

  Endpoint             Average feature size   Statistically overrepresented feature subsets (Fishers test, p value=0.05)
  -------------------- ---------------------- ----------------------------------------------------------------------------
  Histological grade   74                     Nuclear shape (0.013)
  Metastasis           28                     Nuclear shape (0.000)
  Stage                54                     Nuclear shape (0.013) and Basophilic-object shape (0.002)
  Five year survival   37                     Basophilic-region texture (0.000)
  Lymph node spread    34                     Nuclear shape (0.000)

[Figure 5](#AMIAJNL2012001540F5){ref-type="fig"}C,D illustrates scatter plots of area under the curve for inner cross-validation and outer cross-validation performance for models based on tissue (tumor and non-tumor tiles) and tumor tiles, respectively. Each point in the scatter plot is an average performance for one cross-validation iteration. We can observe that the performance in both cases---models based on tumor and tissue tiles---is close to the diagonal, which indicates that inner cross-validation can predict the performance of outer cross-validation. We can also observe that the models based on tumor tiles perform equivalent to or better than the models based on all tissue tiles. We report the average and SD of outer cross-validation performance for all endpoints in [table 2](#AMIAJNL2012001540TB2){ref-type="table"}. For the histological grade and metastasis prediction models, prediction performances based on tumor tiles are more than those based on all tissue tiles with statistical significance (evaluated using a t test). Although this case study adopts a robust analytical pipeline, the classification performances are lower compared to the performances observed in the literature for manually curated sections. Two causes for low prediction performance are various quality issues with TCGA data, that is, tissue folds, pen marks, and out-of-focus regions that are inherent to WSI, and difficulty in predicting clinical endpoints, that is, patient survival, which are not normally targeted by pathologists. Therefore, automatic image quality control, ROI selection in WSI, and clinically informative feature extraction are still open challenges in the field of pathology imaging informatics. Despite these challenges, such CDSS will provide an objective and fast means for clinical diagnosis with minimal user intervention. Moreover, such systems can be trained to diagnose rare subtypes of cancer that are often missed in traditional diagnosis.[@R89] The knowledge extracted by these systems may also contribute to a holistic diagnostic platform by integration with data from other imaging modalities as well as with data from genomic and proteomic experiments[](#AMIAJNL2012001540TB3){ref-type="table"}.[@R90]

###### 

Summary of key methods in each component of a WSI-based clinical decision support system

  Section                                       Subsection                                                                                                                                                                                                                                  Key methods
  --------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Quality control                               Image artifacts                                                                                                                                                                                                                             Tissue folds,[@R13; @R14; @R15] blurred regions,[@R16] and chromatic aberration[@R17]
  Batch effects                                 Color normalization,[@R18; @R19; @R20] batch-invariant color space,[@R21; @R22; @R23] and scale normalization[@R24]                                                                                                                         
  Image description                             Pixel-level features                                                                                                                                                                                                                        Color,[@R38] gray-level intensity profiles,[@R30] Haralick features,[@R23] [@R30] [@R35] [@R36] wavelet and multiwavelet submatrices,[@R30] [@R36] [@R37] Gabor filter responses,[@R23] [@R30] [@R36] and Fractals[@R30] [@R36]
  Object-level features                         Shape[@R47] [@R48] and graph-based topology[@R52; @R53; @R54; @R55; @R56]                                                                                                                                                                   
  Semantic-level features                       Bag-of-features[@R60] and spatial hidden Markov model[@R61]                                                                                                                                                                                 
  Prediction modeling                           ROI selection and tile-based WSI representation                                                                                                                                                                                             ROI selection: supervised[@R13] [@R63; @R64; @R65] and unsupervised[@R66] [@R67]; tile combination: feature[@R49] and prediction[@R22]; multiscale analysis[@R22] [@R23] [@R67] [@R70]
  Informative feature selection and reduction   Feature selection: filter,[@R30] [@R51] [@R53] [@R57] sequential search (wrapper),[@R22] [@R36] [@R91] and random forest (embedded)[@R65]; Feature reduction: PCA,[@R32] [@R39] [@R91] graph embedding,[@R54] ISOMAP,[@R80] and MDS[@R92]   
  Classification                                Multiple classifiers,[@R22] [@R29] [@R36] [@R39] [@R80] boosting,[@R23] [@R80] [@R93] ensemble methods,[@R22] and active learning[@R3] [@R94; @R95; @R96]                                                                                   
  Visualization and exploratory analysis        Unsupervised clustering and high-dimensional feature patterns                                                                                                                                                                               Hierarchal clustering,[@R49] [@R68] [@R72; @R73; @R74] Self-organizing maps,[@R75] [@R76] k-means,[@R58] [@R79] [@R80] and expectation maximization[@R22]
  Virtual microscope and spatial patterns       Image compression,[@R83] [@R84] Google map interface,[@R82] [@R85] [@R86] highlight ROI,[@R56] [@R64] [@R65] [@R67] [@R70] [@R87] annotation,[@R61] [@R62] and spatial variation of features[@R13] [@R71]                                   

MDS, ; PCA, ; ROI, region of interest; WSI, whole-slide image.

![Role of region of interest (ROI) selection on the performance of whole-slide image (WSI)-based prediction models. (A) An example WSI. (B) Tiles in the tumor region (ROI) of the WSI highlighted with green boxes. Scatter plots between the prediction performance (area under the curve; AUC) of inner and outer loop of nested cross-validation for (C) models based on features from tissue tiles, including tumor and non-tumor (normal, necrosis, and stroma) regions; and for (D) tiles in the tumor region only.](amiajnl-2012-001540f05){#AMIAJNL2012001540F5}

Conclusion {#s7}
==========

With the emergence of WSI technology, high-resolution scans of complete tissue biopsy slides are becoming a common clinical practice. Despite the benefits of WSI for histopathological diagnosis, the literature reports that existing CDSS primarily use only rectangular sections of WSI. Moreover, commercial software tools for WSI analysis are also limited because they are typically trained for only a single experimental set-up and only focus on segmenting tissue structures and quantifying a limited set of image descriptors to aid manual histopathological analysis. Based on these systems, we learned that quantitative image features are able to model cancer diagnosis and prognosis. However, the development of CDSS for WSI has been impeded by several informatics challenges: quality control; robust and fast image segmentation; knowledge (semantic-level) models for WSI; and ROI selection. Researchers have developed methods to address these challenges (table 3). However, most studies validate their methods on a limited number of samples and cancer endpoints. To make CDSS for pathology a reality, it is necessary to develop a generalizable system (such as the system described in the case study) that can be applied to multiple cancer endpoints and that is validated using large multibatch datasets. With the availability of large WSI datasets for multiple cancer endpoints in public repositories such as TCGA, the data required to make the necessary advances in pathology imaging informatics research have now become more accessible.
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